ALEC - Alector, Inc.
IEX Last Trade
1.71
-0.010 -0.585%
Share volume: 43,825
Last Updated: Mon 13 Jan 2025 08:30:15 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$1.72
-0.01
-0.58%
Summary score
11%
Profitability
8%
Dept financing
37%
Liquidity
40%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-11.83%
Return on assets
-5.63%
Return on sales
-434.9%
Return on invested capital
424.03%
Total debt ratio
64.27%
Debt ratio change over timeo
-0.61%
Current Ratio
5.32%
Quick Ratio
5.73%
Cash Position Ratio
2.62%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-6.75%
Return on sales
-301.37%
Return on invested capital
0%
Total debt ratio
75.21%
Debt ratio change over timeo
0%
Current Ratio
3.38%
Quick Ratio
0%
Cash Position Ratio
0.36%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-5.68%
Return on sales
-275.01%
Return on invested capital
0%
Total debt ratio
71.85%
Debt ratio change over time
0%
Current Ratio
3.53%
Quick Ratio
0%
Cash Position Ratio
0.44%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-89.86%
Return on assets
-98.65%
Return on sales
-133.2%
Return on invested capital
-255.57%
Total debt ratio
-61.32%
Debt ratio change over time
-0.61%
Current Ratio
2.37%
Quick Ratio
0.26%
Cash Position Ratio
0.55%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | ALEC | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | -11.83% | 13.03% | 18.15% | 6.63% |
Return on assets | -5.63% | 2.28% | 3.22% | 5.84% |
Return on sales | -434.9% | 27.95% | 31.46% | 43.41% |
Return on invested capital | 424.03% | 2.07% | 5.53% | 34.89% |
Profitability | 25% | 44% | 57% | 61% |
Total debt ratio | 64.27% | 91.02% | 90.77% | 24.67% |
Debt ratio change over time | -0.61% | 435.59% | 17.23% | -0.06% |
Dept financing | 18% | 50% | 26% | 7% |
Current Ratio | 3.38% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 0.36% | 0.31% | 0.49% | 2.77% |
Liquididy | 70% | 10% | 22% | 62% |
Short-term ratios | ALEC | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 5.91% |
Return on assets | -6.75% | 1.6% | 2.14% | 4.97% |
Return on sales | -301.37% | 24.8% | 18.91% | 42.59% |
Return on invested capital | 0% | 0% | 0% | 23.7% |
Profitability | 0% | 23% | 22% | 100% |
Total debt ratio | 75.21% | 94.49% | 93.35% | 24.56% |
Debt ratio change over time | 0% | 0% | 0% | -0.62% |
Dept financing | 45% | 25% | 25% | 6% |
Current Ratio | 3.38% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 0.36% | 0.31% | 0.49% | 2.77% |
Liquididy | 26% | 14% | 21% | 75% |